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Objective: To examine the validity of the PainMatcher in 
chronic pain. 
Design: Comparison of parallel pain estimates from visual 
analogue scales with electrical stimulus magnitude matching. 
Patients: Thirty-one patients with chronic musculoskeletal 
pain. 
Methods: Twice a day ongoing pain was rated on a stand-
ard 100-mm visual analogue scale, and thereafter magnitude 
matching was performed using a PainMatcher. The sensory 
threshold to electrical stimulation was tested twice on sepa-
rate occasions. 
Results: In 438 observations visual analogue scale ranged 
from 3 to 95 (median 41) mm, and PainMatcher magnitudes 
from 2.67 to 27.67 (median 6.67; mean 7.78) steps. There was 
little correlation between visual analogue scale and magni-
tude data (r = 0.29; p < 0.0001). The mean sensory threshold 
was 3.67 steps, indicating that the PainMatcher, on average, 
stimulated at 2.1 times the perception threshold at matching 
point. 
Conclusion: Electrical magnitude matching of chronic pain 
intensity elicited limited activation of nerve fibres at 2.0–2.2 
times sensory threshold, indicating that the induced pain 
was evoked by coarse nociceptive Aδ fibres. While the visual 
analogue scale estimates covered the whole range of the in-
strument, the PainMatcher readings utilized only a small 
part of the instrument range and, importantly, had little or 
no relation to the visual analogue scale estimates. The valid-
ity of the PainMatcher procedure is doubtful.
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INTRODUCTION
Self-assessment of pain intensity is commonly used to evalu-
ate the therapeutic effects of clinical interventions and in 
clinical research (1). Techniques to assess pain intensity are 
either rating scales or matching methods, where patients are 
instructed to match their clinical pain to an induced sensation 
(2). However, a person’s reaction to pain is individual and 
highly dependent on the context (3). 
The most common instrument for assessing clinical pain 
intensity is the visual analogue scale (VAS) (4–8). A difference 
of 9–13 mm on the scale has been found to correspond to a 
clinically significant change in acute pain conditions (9–12). 
The VAS is valid and reliable (13) in chronic pain as well as 
in experimentally induced pain (6, 7), and is more sensitive 
than verbal rating scales (14–17). 
There is, however, renewed interest in magnitude matching 
of pain intensity, since many patients have difficulties in rating 
pain as a visual analogue amplitude measure (18). It has been 
argued that the use of direct matching to an induced experi-
mental pain might be easier for the patient and might give a 
more objective assessment than comparing the pain intensity 
with a word or setting a mark on a line (19). 
A recently developed instrument, the PainMatcher, is based 
on such perceptual matching by using electrical stimulation of 
sensory nerve fibres in the fingers (19). This stimulator works 
at a constant current amplitude and increases the pulse width, 
i.e. the electrical charge, in steps over time until the patient 
lets go of the instrument. This technique, to compare the mag-
nitude of an electrically induced experimental pain sensation 
to a perceived clinical pain, has been reported to be as reliable 
and as sensitive to pain intensity changes as the VAS and the 
numerical rating scale (NRS) in patients with chronic nocicep-
tive or neuropathic pain (19). It has also been reported to be 
valid for matching clinical and induced acute oral pain (20), 
and pre- and post-operative gynaecological pain (21). There 
have been greater difficulties, however, in using the instrument 
to assess pain from chronic whiplash injury, with a possible 
bias related to unpleasantness of the stimulation (22).
The aim of this study was to examine the validity of the 
PainMatcher technique in assessing pain intensity by com-
paring its data with parallel VAS estimates in patients with 
chronic pain. We chose to carry out the assessments in patients 
participating in a pain rehabilitation programme that did not 
have pain reduction as the main purpose, but increased activ-
ity. The assessments were carried out during a 2-week period, 
allowing spontaneous and activity-related variations of pain 
intensity. The research questions were: (i) Is there agreement 
between assessments with the 2 methods at the same point in 
time? (ii) Is the sensory threshold for electrical stimulation 
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stable in individual subjects? (iii) Which cutaneous nerve fibres 
are activated at the stimulation intensities commonly produced 
by the PainMatcher? and (iv) Does the PainMatcher give valid 
measures of perceived chronic pain intensity?
METHODS
Patients
Patients disabled by chronic musculoskeletal pain were recruited dur-
ing participation in a Commission on Accreditation of Rehabilitation 
Facilities (CARF)-accredited (23), 5-week cognitive-behaviourally 
oriented interdisciplinary pain rehabilitation programme at Umeå 
University Hospital in Sweden. They were referred to the rehabil-
itation centre with chronic pain present for a minimum of 6 months, the 
majority coming from primary care physicians in the area. Only those 
with whiplash-associated disorders present for less than 1.5 years were 
excluded, since they were managed in a separate programme. 
Thirty-one adult patients of working age agreed to participate in 
the study (24 women; mean age 39.3 years, and 7 men; mean age 43.2 
years). The subjects gave written consent to participate and the study 
was approved by the local ethics committee. The inclusion criteria for 
the pain rehabilitation programme described above were: (i) disabling 
chronic pain from the musculoskeletal system (on sick leave or with 
major interference in daily life causing treatment seeking behaviour 
due to pain of at least 6 months duration); (ii) age 18–65 years; (iii) 
further medical investigations not needed; (iv) written consent to 
participate and attend the activities in the rehabilitation programme; 
and (v) agreement not to participate in other parallel treatments. The 
exclusion criteria were: (i) ongoing major somatic (e.g. inflammatory), 
or psychiatric disease; (ii) a history of significant substance abuse; 
and (iii) obvious state of acute crisis (major recent adverse life event 
as found on interview). Furthermore, subjects with sensory or motor 
deficits in the left hand on clinical testing (see Procedure) or having 
a pacemaker (contraindication) were excluded.
PainMatcher
The PainMatcher® (Cefar-Compex Scandinavia Inc., Malmö, Sweden) 
is a commercially available magnitude matching equipment. The in-
strument is held in the thumb and index fingers of the left hand and, 
on compressing the grip, which consists of carbon rubber electrodes, it 
sends a constant current of 15 mA square wave pulses at 10 Hz through 
the tissue. It can adjust for differences in skin resistance up to 13 kOhm. 
The pulse duration slowly increases from 0 to 450 µsec in increments of 
7.5 µsec in 60 steps, quantifying the electrical charge delivered (pulse 
current times pulse duration) until the patient lets go of the grip. The 
display shows the final pulse duration. The instrument is used to match 
present clinical pain with the evoked experimental pain generated by 
the electrical stimulation of the volar skin of the fingers.
Procedure
The electrical stimulation was started when the patient squeezed the 
electrodes. For the somatosensory perception threshold the subject 
was instructed to interrupt the current (by letting go of the instrument) 
when they felt the slightest sensation. For pain magnitude matching, 
they were told to interrupt the current when the experimental pain 
from the stimulus current was equal (matched) in intensity to their 
clinical pain level. A value between 1 and 60 was stored in the instru-
ment solid state memory, and it was set not to display the data to the 
patients, thus blinding the patient to the test results. The patients were 
always guided by one of 3 assistants, who were trained and familiar 
with the technique.
Protocol
All patients were first introduced to and acquainted with the PainMatcher 
and a mechanical 100-mm (plasticized) VAS (15, 17) before the assess-
ments. They were also given written information about the procedure. To 
standardize the procedure the magnitude matching was always carried out 
after the VAS estimation. However, it has been shown that the order of 
pain assessment using different scales does not affect the results (19).
The patients rated their present pain intensity on the 100-mm plasti-
cized VAS with the end-points “no pain” and “worst possible pain”, after 
which the scale was moved out of sight. The PainMatcher instrument was 
then used to perform 3 consecutive magnitude matchings of the present 
pain intensity (mean used for analyses). When possible, the procedure 
was repeated twice a day for up to 2 weeks, giving a maximum of 20 
paired observations. Before the magnitude assessments each patient’s 
sensory perception threshold was assessed 3 times with 1–3 min intervals 
(mean values used for analyses) at the 2 first occasions. 
Statistical analyses
For the electrical stimulation charges, consisting of quantitative data 
on pulse durations for perception thresholds and pain magnitudes, 
we employed parametric statistics, using the Statistical Package for 
the Social Sciences (SPSS, version 15) for statistical analyses. The 
mean of the 3 PainMatcher estimates at each session was used for 
calculations of mean and 95% confidence interval (95% CI) at group 
levels. For additional clarity, median and range were also calculated. 
There is ongoing discussion as to whether VAS observations should 
Fig. 1. (A) All observations of assessed ongoing pain intensity on 
standard visual analogue scale (VAS) (0–100 mm; x-axis) and PainMatcher 
readings of charge magnitude in arbitrary units (0–60 steps; y-axis). (B) 
As for A, but y-axis data represent PainMatcher pulse duration ratios (in 
relation to individual sensory thresholds, see Methods).
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be considered as categorical or numerical data (24, 25). We chose to 
analyse them as being categorical data in the present study. To study 
the agreement between the VAS and the PainMatcher assessments 
of pain intensity, Spearman’s rank correlation test was used for data 
from all subjects as a group, as well as in individual analyses for all 
subjects with ≥ 15 observations. 
To analyse which cutaneous nerve fibres were activated by the 
PainMatcher stimulation (cf. (26)), the ratio between the stimulation 
charge from the PainMatcher estimates matching present clinical 
pain and the charge at the threshold for sensory perception at the first 
measurement was calculated for all observations. 
RESULTS
Visual analogue scale estimates and PainMatcher readings 
In the 438 observations (one outlier at PainMatcher duration 
60 was excluded) from 31 patients, VAS ranged from 3 to 95 
(median 41) mm, whereas the PainMatcher magnitudes ranged 
from 2.67 to 27.67 (median 6.67) steps (Fig. 1A). Some patients 
gave personal comments about the VAS and about the Pain-
Matcher, for example: “It is difficult to relate to the VAS, not 
having been free from pain for many years, it is easier having 
something to compare with – like when using the PainMatcher”. 
One patient experienced the PainMatcher stimulation as very 
uncomfortable and commented: “It feels like holding an electri-
cal cattle fence”. Two patients expressed that the stimulation 
intensity increased so quickly that they were not able to let go 
of the apparatus in time to mark the perceived pain intensity 
correctly. In fact, 16 out of 438 PainMatcher observations 
(3.6%) had pulse duration ratios below 1 (see below and Fig. 
1B), indicating inadequate handling of the procedure by the 
patient (sensory threshold above level of matched pain).
Correlations between visual analogue scale and PainMatcher 
assessments
The paired assessments of pain intensity with VAS estimates 
and PainMatcher pulse durations (n = 438) for the whole group 
Fig. 2. Individual data-sets for patients with ≥ 15 measurements, showing the relation between visual analogue scale estimates and PainMatcher pulse 
duration ratios. For larger view in one patient see Fig. 3. 
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of patients (n = 31), performed morning and evening for up to 
10 consecutive weekdays showed little correlation (r = 0.29; 
p < 0.0001; Spearman’s test) (Fig. 1A). This plot also reveals 
that none of the patients employed the upper half of the stimu-
lation range of the PainMatcher (1–60 steps), whereas the full 
VAS range was used.
A plot of pulse duration ratios (cf. below) in relation to VAS 
estimates can be seen in Fig. 1B. It is evident that there is no 
correlation between the 2 types of pain intensity assessments 
(r = 0.17; p < 0.0001; Spearman’s test) when pooling data 
from all patients. The corresponding individual data-sets for 
the 20 patients with more than 15 observations are given in 
Figs. 2 and 3, which reveals that in less than one-third of the 
cases is there a visible correlation between VAS estimates and 
PainMatcher pulse duration ratios. For those subjects (in total 
366 observations), the individual correlations between VAS 
and PainMatcher assessments using Spearman’s test varied 
dramatically with correlation coefficients from r = 0.16 to 
r = 0.86, with a median of r = 0.64. 
Nerve fibres activated by PainMatcher stimulus charges
The mean PainMatcher sensory perception threshold of the 
volar skin areas of digiti I–II was 3.67 (95% CI 3.46–3.88) 
steps (× 7.5 = 27.5 µsec pulse duration). There was no signifi-
cant difference between the mean thresholds at the first and 
second measurement occasions (paired t-test). Such cutane-
ous nerve threshold determinations are usually stable over 
time (26).
The mean PainMatcher magnitude estimation of chronic 
pain intensity in our subjects from all observations (n = 438) 
was 7.78 (95% CI 7.40–8.16) steps (× 7.5 = 58.3 µsec pulse 
duration). This indicates that the PainMatcher, on average, 
stimulated at around 58.3/27.5 = 2.1 (95% CI 2.0–2.2) times the 
perception threshold when the patient let go of the instrument, 
i.e. when the patient found the intensity of his/her chronic pain 
to match the experimental pain in the digital skin areas, evoked 
by the electrical stimulus.
To further examine which cutaneous nerve fibres that may 
have been stimulated by the actual PainMatcher stimulus 
charges, we chose to plot, as an example, the ratios between 
the magnitudes of the tenth observed experimental pain evoked 
stimulus and those at the threshold, in each of the subjects 
contributing pain assessments 15 times or more (cf. above; 
Fig. 4). It can be seen that the stimulation intensities (pulse 
duration ratios) varied between 1.2 and 5.4 times the sensory 
perception threshold, more or less irrespective of the corre-
sponding actual VAS estimates. 
DISCUSSION
Assessing pain intensity by way of the 100-mm VAS is by 
far the most commonly used technique in pain research and 
management (12, 13, 15, 17). Even if single researchers have 
recently argued that the VAS is less than adequate (24, 25), 
there is overwhelming evidence for the validity and the reli-
ability of the VAS in acute pain assessment (12, 14, 17, 27–29). 
The VAS scale is also often used for chronic pain intensity even 
if chronic pain is associated with multiple dimensions, such as 
intensity, distress, affect, and impact on activity, which might 
confound the pain intensity ratings (30). On the other hand, 
a similar problem would hold true for the PainMatcher when 
used in chronic pain.
The approach of assessing pain intensity by the person 
matching his/her current pain with an experimentally induced 
sensation (2), such as that from an electrical stimulation, has 
recently been advocated through the PainMatcher technique 
(19). The present data show, however, that while the VAS 
estimates related to ongoing clinical pain in a group of patients 
with fluctuating musculoskeletal chronic pain covered the 
whole range of the VAS, the PainMatcher readings had little 
or no relation to the corresponding VAS estimates. As is amply 
demonstrated here, a certain PainMatcher stimulus charge may 
correspond to almost any reported VAS pain intensity, both at 
the group and at the individual levels. 
Fig. 4. Example of visual analogue scale (VAS) estimates and PainMatcher 
pulse duration ratios, from the tenth observed experimental pain evoked 
stimulus in each of the subjects (n = 20) contributing pain assessments 
15 times or more.
Fig. 3. Data from patient 31, enlarged to display scales and axis titles. 
VAS: visual analogue scale.
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The validity of matching methods has been questioned 
previously, since the affective components in clinical pain 
are not present when a person is stimulated with a pain that is 
controlled by the person themselves, both regarding intensity 
and duration. However, it has been argued that using direct pain 
matching might be easier for the patient to manage, as well as 
giving a more objective assessment than comparing the pain 
intensity to a word or to setting a mark on a line (31, 32).
Furthermore, the PainMatcher readings utilized only a small 
part of the instrument range. The same phenomenon appears 
in the studies published by Lundeberg and colleagues (19, 33), 
that the patients and subjects only use the lower third of the 
stimulation range of the PainMatcher instrument to match their 
full range of pain intensities. This observation is to be expected 
if the instrument stimulates a homogenous group of nerve fibres 
with a narrow range of electrical stimulation thresholds.
An important aspect is that the use of electrical stimuli for 
eliciting experimental pain in a matching technique, such as 
with the PainMatcher, introduces a confounder. When assessing 
sensory function, the sensory threshold (34) can be measured 
by increasing the stimulus continuously to a level where it is 
detectable, and thereafter decreasing it to a level where it is 
no longer detectable. When the electrical stimulation intensity 
has reached the sensory threshold, first the tactile Aβ nerve 
fibres are selectively activated (26, 35). When the current is 
increased, the threshold of Aδ nociceptive fibres is approached 
at 2–10 times the sensory threshold. Since the order of activa-
tion is connected to the nerve fibre diameter, the thin unmyeli-
nated nociceptive C fibres are activated only at a much higher 
intensity (> 30 times) than that of Aβ fibres (35, 36).
The present results indicate that the PainMatcher unit was 
usually working at around 2.1 times the threshold of large Aβ 
fibres and merely straddling the threshold of Aδ fibres when 
the patient let go of the instrument (in our sample 1.2–5.4 
times the sensory threshold, Fig. 4). In the study by Sang 
et al. (26) the mean of the ratio between pain threshold and 
tactile threshold was 10.9 (range 2.0–28.3). Since it is usu-
ally agreed that only tactile Aβ fibres occur in the range 1–2 
times the sensory threshold (35), the present PainMatcher 
ranges indicate firstly, that precision was low (sometimes only 
tactile stimulation occurred (Fig. 1B), and secondly, that the 
magnitude matching of chronic pain intensity elicited a very 
limited activation of myelinated nociceptive fibres (mean 2.1; 
range 0.8–7.6 times threshold) (Fig. 1B). This means that the 
PainMatcher induced experimental pain was always evoked by 
the coarsest Aδ nerve fibres, and never by C fibres (26, 35). In 
fact, it can be questioned whether the PainMatcher procedure 
measures anything but nociceptive Aδ nerve fibre thresholds. 
Furthermore, it is tempting to speculate that other mechanisms 
were in operation, such as phenomena related to fear/avoid-
ance and to sensitization or modulation via descending fibres, 
e.g. via diffuse noxious inhibitory controls that may influence 
the reaction (37).
It should be remembered that heat-sensitive nociceptive C 
fibres (38, 39) were most certainly activated by the old heat 
lamp technique (dolorimetry) by Hardy et al. (2), and further 
developed by Lipman et al. (40, 41). On the contrary, the ex-
perimental pain elicited by the “artificial” PainMatcher stimuli 
utilizes only a small part of the available nociceptor channels to 
the brain compared with heat stimulus matching. This qualita-
tive difference may explain the lack of concordance between 
the VAS estimates and the PainMatcher readings, pointing to 
parallel, but independent, processes.
However, there may be other explanations. For example, in 
the study by Alstergren & Förström (20, Fig. 6 in their paper), 
almost half of the patients assessed their ongoing clinical pain 
intensity as being lower than their pain threshold, indicating 
that the PainMatcher measured something else than pain in-
tensity, or was simply too difficult to master for the patients. It 
could even be that the patients experienced the stimulation so 
disagree able that they let go of the PainMatcher prematurely 
(20). These authors were of the opinion that since a high level 
of discomfort during a pain assessment resembles chronic pain, 
the instrument would be suitable when assessing pain inten-
sity in patients with chronic pain. Our results do not confirm 
this hypothesis. A recent study by Bunketorp Käll et al. (22) 
indicates that one bias may actually be that the PainMatcher 
assessments are partly associated with unpleasantness rather 
than with pain.
Taken together, our results do not support the use of the 
PainMatcher as a valid outcome measure for assessing pain 
intensity, at least not in patients with chronic musculoskeletal 
pain, which to a large extent is transmitted by C fibres (group 
IV fibres; (42)). Earlier studies have found the PainMatcher 
to be as reliable as the VAS and the NRS, more for acute pain 
situations (19–21, 43) than for chronic ones (19); but see 
Bunketorp et al. (22) who raise the concerns about the as-
sociations with unpleasantness.. Since the validity is now 
questioned, the earlier reported reliability and repeatability 
(19, 33, 43) can be considered to be of minor importance for 
the clinical use of this instrument. It is probable that the previ-
ously reported reliability of the PainMatcher technique is due 
to a reliable Aδ nerve threshold determination rather than to 
a matching phenomenon. Hence, our conclusion is that the 
validity of the PainMatcher procedure is doubtful.
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